MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 05-16-2026
Streamline Health Solutions Accounts Receivables 2011-2026 | STRM
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Streamline Health Solutions
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.58 M | 4.24 M | 7.72 M | 3.82 M | 2.93 M | 3.17 M | 2.93 M | 3 M | 4.49 M | 4.2 M | 6.94 M | 8 M | 8.69 M | 4.48 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.69 M | 1.58 M | 4.73 M |
Quarterly Accounts Receivables Streamline Health Solutions
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.82 M | 2.52 M | 4.18 M | 2.82 M | 2.52 M | 4.71 M | 4.24 M | 3.65 M | 2.79 M | 4.28 M | 7.72 M | 3.32 M | 3.54 M | 4.66 M | 2.93 M | 3.29 M | 2.62 M | 3.19 M | 2.02 M | 937 K | 418 K | 688 K | 2.93 M | 2.21 M | 2.76 M | 2.89 M | 3 M | 1.56 M | 2.24 M | 2.82 M | 4.49 M | 2.53 M | 4.62 M | 3.72 M | 4.2 M | 2.96 M | 3.8 M | 4.05 M | 6.94 M | 3.43 M | 9.03 M | 6.26 M | 8 M | 5.92 M | 10.6 M | 9 M | 8.69 M | 6.89 M | 10.8 M | 9.59 M | 4.48 M | 3.39 M | 2.19 M | 2.8 M | 2.62 M | 2.42 M | 2.15 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10.8 M | 418 K | 4.14 M |
Accounts Receivables of other stocks in the Health information services industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
1.16 B | - | - | $ 27.9 B |  USA |
 |
Accolade
ACCD
|
9.11 M | - | 0.29 % | $ 206 M | USA |
 |
Evolent Health
EVH
|
311 M | $ 3.87 | -2.03 % | $ 442 M | USA |
 |
Change Healthcare
CHNG
|
720 M | - | - | $ 9.03 B | USA |
 |
Computer Programs and Systems
CPSI
|
55 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
480 M | - | - | $ 2.94 B | USA |
 |
HealthEquity
HQY
|
124 M | $ 87.84 | -0.31 % | $ 7.57 B | USA |
 |
iCAD
ICAD
|
7.21 M | - | - | $ 102 M | USA |
 |
GoodRx Holdings
GDRX
|
236 M | $ 2.79 | 5.28 % | $ 994 M | USA |
 |
Akerna Corp.
KERN
|
2.13 M | - | - | $ 161 M | USA |
 |
10x Genomics
TXG
|
47 M | $ 24.74 | 4.48 % | $ 3.09 B | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
119 M | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
15.1 M | - | -0.58 % | $ 51.7 M | USA |
 |
1Life Healthcare
ONEM
|
137 M | - | - | $ 3.37 B | USA |
 |
NextGen Healthcare
NXGN
|
77.5 M | - | - | $ 1.6 B | USA |
 |
Premier
PINC
|
99.1 M | - | - | $ 2.33 B | USA |
 |
Health Catalyst
HCAT
|
59.1 M | $ 1.25 | -3.1 % | $ 87.4 M | USA |
 |
OptimizeRx Corporation
OPRX
|
37.8 M | $ 4.8 | -2.83 % | $ 89.1 M | USA |
 |
Schrödinger
SDGR
|
83 M | $ 13.28 | -0.15 % | $ 975 M | USA |
 |
Phreesia
PHR
|
97.5 M | $ 8.96 | 0.39 % | $ 535 M | USA |
 |
R1 RCM
RCM
|
131 M | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
193 M | $ 6.66 | 1.37 % | $ 1.17 B | USA |
 |
Signify Health
SGFY
|
156 M | - | -0.02 % | $ 7.21 B | USA |
 |
NantHealth
NH
|
5.95 M | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
313 K | - | - | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
49.7 M | $ 8.25 | 3.64 % | $ 132 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
19.3 M | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
32.2 M | $ 24.01 | 0.84 % | $ 721 M | USA |
 |
Omnicell
OMCL
|
217 M | $ 44.34 | -0.17 % | $ 2.04 B | USA |
 |
Progyny
PGNY
|
220 M | $ 25.31 | 1.71 % | $ 2.16 B | USA |
 |
So-Young International
SY
|
51.5 M | $ 1.9 | -14.8 % | $ 148 M |  China |
 |
Veeva Systems
VEEV
|
1.26 B | $ 159.18 | -0.62 % | $ 26.1 B | USA |
 |
Zhongchao
ZCMD
|
10.3 M | $ 1.43 | - | $ 4.89 M | China |